H3 antagonists (Evotec)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameH3 antagonists (Evotec)
Drug Alias NameEDC-2 (Evotec)EDC-3 (Evotec)EVT-502EVT-501
ClassificationSmall molecules
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsCognition DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec SE
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec SE
Active IndicationsN/A
Inactive IndicationsCognition DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A